Cencora to acquire American Oncology Network
COR•Cencora will acquire American Oncology Network in a deal valued at $2.40 billion in enterprise value, including up to $100 million in contingent value rights. Cencora expects the acquisition to add to adjusted diluted EPS in its second year after closing and forecasts fiscal 2026 adjusted diluted EPS of at least $17.90.
1. Deal terms
Cencora will pay $1.70 billion to increase its ownership of American Oncology Network to 75%, with a 25% equity rollover. The deal values American Oncology Network at $2.40 billion in enterprise value, including up to $100 million in contingent value rights.
2. Earnings outlook
Cencora expects the acquisition to be accretive to adjusted diluted EPS in its second year after closing. It expects fiscal 2026 adjusted diluted EPS of at least $17.90.
